Subacute toxicity of colistin methanesulfonate in rats: Comparison of various intravenous dosage regimens

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 3, 2008, Pages 1159-1161

  Wallace, Stephanie J ^a   Li, Jian ^a   Nation, Roger L ^a   Rayner, Craig R ^a,e   Taylor, David ^a   Middleton, Deborah ^b   Milne, Robert W ^c   Coulthard, Kingsley ^c,d   Turnidge, John D ^d  

^a MONASH UNIVERSITY   (Australia)

^b CSIRO   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIMETHATE; PLACEBO;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; HISTOLOGY; KIDNEY INJURY; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT DURATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BEHAVIOR, ANIMAL; COLISTIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY; KIDNEY DISEASES; MESYLATES; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 40549083693     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01101-07     Document Type: Article

References (15)

1. Barnett, M., S. R. Bushby, and S. Wilkinson. 1964. Sodium sulphomethyl derivatives of polymyxins. Br. J. Pharmacol. 23:552-574.
2. Bergen, P. J., J. Li, C. R. Rayner, and R. L. Nation. 2006. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 50:1953-1958.
3. Costa, L. G., H. Deng, C. J. Calleman, and E. Bergmark. 1995. Evaluation of the neurotoxicity of glycidamide, an epoxide metabolite of acrylamide: behavioural, neurochemical and morphological studies. Toxicology 98:151-161.
4. Infectious Diseases Society of America. 2004. Bad bugs, no drugs. Infectious Diseases Society of America, Arlington, VA. http://www.idsociety.org/ badbugsnodrugs.html. Accessed 17 December 2007.
5. Lewis, J. R., and S. A. Lewis. 2004. Colistin interactions with the mammalian urothelium. Am. J. Physiol. Cell Physiol. 286:C913-C922.
6. Li, J., K. Coulthard, R. Milne, R. L. Nation, S. Conway, D. Peckham, C. Etherington, and J. Turnidge. 2003. Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis. J. Antimicrob. Chemother. 52:987-992.
7. Li, J., R. W. Milne, R. L. Nation, J. D. Turnidge, and K. Coulthard. 2003. Stability of colistin and colistin methanesulfonate in aqueous media and plasma studied by high-performance liquid chromatography. Antimicrob. Agents Chemother. 47:1364-1370.
8. Li, J., R. W. Milne, R. L. Nation, J. D. Turnidge, K. Coulthard, and D. W. Johnson. 2001. A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography. J. Chromatogr. B 761:167-175.
9. Li, J., R. W. Milne, R. L. Nation, J. D. Turnidge, K. Coulthard, and J. Valentine. 2002. Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography. Antimicrob. Agents Chemother. 46:3304-3307.
10. Li, J., R. W. Milne, R. L. Nation, J. D. Turnidge, T. C. Smeaton, and K. Coulthard. 2004. Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate. J. Antimicrob. Chemother. 53:837-840.
11. Li, J., R. L. Nation, R. W. Milne, J. D. Turnidge, and K. Coulthard. 2005. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int. J. Antimicrob. Agents 25:11-25.
12. Meyer, O. A., H. A. Tilson, W. C. Byrd, and M. T. Riley. 1979. A method for routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav. Toxicol. 1:233-236.
13. Reiter, L. W. 1978. Use of activity measures in behavioural toxicology. Environ. Health Perspect. 26:9-20.
14. Rosenvinge, A., T. Pressler, and N. Hoiby. 2005. Colistin intravenously is a safe and effective treatment of multidrug-resistant microorganisms in cystic fibrosis. J. Cyst. Fibros. 4:S26-S33.
15. U.S. Environmental Protection Agency. 1996. Health effects test guidelines: OPPTS 870.6200 neurotoxicity screening battery. U.S. Environmental Protection Agency, Washington, DC.